[Federal Register: November 7, 2007 (Volume 72, Number 215)]
[Notices]
[Page 62871]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07no07-82]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated August 1, 2007 and published in the Federal
Register on August 9, 2007, (72 FR 44860), Cambrex North Brunswick,
Inc., Technology Centre of New Jersey, 661 Highway One, North
Brunswick, New Jersey 08902, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of
Phenylacetone (8501), a basic class of controlled substance listed in
schedule II.
The company plans to import the listed controlled substance to
manufacture amphetamine.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Cambrex North Brunswick, Inc. to import the basic class
of controlled substance is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Cambrex North Brunswick, Inc. to ensure that the company's registration
is consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic class of controlled substance listed.
Dated: October 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-21865 Filed 11-6-07; 8:45 am]
BILLING CODE 4410-09-P